|
Baseline clinical characteristics
| | | |
|
Age (range)
|
60.8 (47-72)
|
61.2 (46-75)
|
0.78
|
|
BMI (range)
|
27.8 (18.8-40.0)
|
27.1 (20.1-38.5)
|
0.28
|
|
Diabetes (%)
|
4 (6.4%)
|
6 (10.3%)
|
0.74
|
|
PVD (%)
|
1 (1.6%)
|
1 (1.7%)
|
0.96
|
|
History of narcotics use (%)
|
0 (0%)
|
1 (3.1%)
|
0.48
|
|
PSA (range, ng/mL)
|
6.2 (0.9-24.0)
|
6.6 (0.9-25.7)
|
0.54
|
|
Operative time (mean ± SD, minutes)
|
186 ± 79
|
166 ± 80
|
0.18
|
|
Preoperative Gleason score
| | |
0.84
|
|
6
|
19 (32%)
|
22 (39%)
|
|
7
|
34 (58%)
|
28 (49%)
|
|
≥8
|
6 (10%)
|
7 (12%)
|
|
Intra-operative medications
| | | |
|
Opiates (mean ± SD, mg MED)
|
94.1 ± 39.6
|
89.3 ± 38.2
|
0.51
|
|
Ketorolac usage
|
38%
|
34%
|
0.63
|
